IFP Advisors’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
PFSRSONJ
AP
FFO
SS
IFP Advisors's EIKN Position: Q2 2026 in Review
IFP Advisors opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 918 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #3275 among its holdings.
5 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.
- IFP Advisors held 918 shares of Eikon Therapeutics worth $12K as of Q2 2026.
- Eikon Therapeutics was a new IFP Advisors position in Q2 2026.
- Eikon Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3275 holding.
- 5 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.